Table 1.
Study and participant characteristics.
| Characteristics | N | % | |
|---|---|---|---|
| Participant characteristics | Minority group* | ||
| Black or African American | 1716 | 17.6 | |
| Hispanic or Latinx | 6556 | 67.2 | |
| Asian | 1154 | 11.8 | |
| American Indian or Alaska Native | 97 | 1.0 | |
| Sexual and Gender Minority | 173 | 1.8 | |
| Not specified/“Other” minority races | 53 | 0.5 | |
| Study characteristics | Minority group | ||
| Black or African American | 4 | 44.4 | |
| Hispanic or Latinx | 2 | 22.2 | |
| Asian | 3 | 33.3 | |
| American Indian or Alaska Native | 1 | 11.1 | |
| Sexual and Gender Minority | 2 | 22.2 | |
| Not specified/”Other” minority races | 1 | 11.1 | |
| Genders enrolled | |||
| Female only | 7 | 77.8 | |
| Male only | 1 | 11.1 | |
| Female and male | 1 | 11.1 | |
| Intervention participants | |||
| Adolescents/young adults only | 5 | 55.6 | |
| Parents of Minors | 1 | 11.1 | |
| Parents and Minors | 3 | 33.3 | |
| Vaccination status at enrollment | |||
| Unvaccinated | 6 | 66.7 | |
| Received first dose of series | 2 | 22.2 | |
| Any number of doses, incomplete series | 1 | 11.1 | |
| Publication year | |||
| 2015-2016 | 6 | 66.7 | |
| 2017-2018 | 3 | 33.3 | |
| Study design | |||
| RCT | 8 | 88.9 | |
| Non-randomized | 1 | 11.1 | |
| Sample size | |||
| <100 | 2 | 22.2 | |
| 100-500 | 6 | 66.7 | |
| 500-1000 | 0 | 0 | |
| >1000 | 1 | 11.1 | |
*Minority groups are defined here using race and ethnicity classifications of the U.S. Census Bureau [22]. Sexual and gender minority populations include, but are not limited to, individuals who identify as lesbian, gay, bisexual, asexual, transgender, two-spirit, queer, and/or intersex, as defined by the National Institutes of Health Sexual and Gender Minority Research Office [23].